Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines - PubMed (original) (raw)
Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines
Feng Guo et al. Mol Immunol. 2011 Oct.
Abstract
Dysregulation of Maspin expression and constitutive activation of NF-κB subunits are important events in tumorigenesis of prostate cancer. Recent finding points that RelB, which contributes to the alternative NF-κB activity, interferes with carcinogenesis in the prostate. We report here, that both the classical and the alternative NF-κB activities are constitutively present in androgen-insensitive human prostate cancer cells. Maspin and RelB expression is correlated negatively in prostate cancer tissues at the later stage. TNF-α signaling triggers the nuclear accumulation of RelB and the concomitant reduction of Maspin expression in a time-dependent manner. In addition, the proteasome inhibitor-induced Maspin expression is accompanied by the reduction of RelB expression. A successful depletion of RelB expression, but not RelA expression, induces Maspin expression. RelB-deficiency abrogates the proteasome inhibitor-induced Maspin expression. Moreover, we demonstrate that the enforced expression of RelB protein in prostate cancer cells inhibits Maspin expression. We propose that RelB is an essential molecule controlling the endogenous and the proteasome inhibitor-induced Maspin expression. Developing a RelB-targeted therapeutic intervention, which might be coupled with the induction of a tumor suppressor Maspin, is valuable in treating advanced, metastatic prostate cancer.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
- [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
Ma L, Shen YY, Zhou P, Zhou J, Guo F. Ma L, et al. Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):165-8. doi: 10.3760/cma.j.issn.0253-3766.2012.03.002. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780967 Chinese. - The NF-κB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells.
Wang J, Yi S, Zhou J, Zhang Y, Guo F. Wang J, et al. Int J Oncol. 2016 Jul;49(1):381-92. doi: 10.3892/ijo.2016.3500. Epub 2016 Apr 25. Int J Oncol. 2016. PMID: 27121503 - Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S. Reddy GP, et al. J Cell Biochem. 2006 Aug 15;98(6):1408-23. doi: 10.1002/jcb.20927. J Cell Biochem. 2006. PMID: 16619263 Review. - NF-κB pathways in hematological malignancies.
Gasparini C, Celeghini C, Monasta L, Zauli G. Gasparini C, et al. Cell Mol Life Sci. 2014 Jun;71(11):2083-102. doi: 10.1007/s00018-013-1545-4. Epub 2014 Jan 14. Cell Mol Life Sci. 2014. PMID: 24419302 Free PMC article. Review.
Cited by
- RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J, Zhou P, Wang W, Sun A, Guo F. Xu J, et al. J Mol Med (Berl). 2014 Jan;92(1):77-92. doi: 10.1007/s00109-013-1081-6. Epub 2013 Sep 17. J Mol Med (Berl). 2014. PMID: 24042463 - The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells.
Qin H, Zhou J, Xu J, Cheng L, Tang Z, Ma H, Guo F. Qin H, et al. Cancer Cell Int. 2018 Jun 26;18:88. doi: 10.1186/s12935-018-0580-5. eCollection 2018. Cancer Cell Int. 2018. PMID: 29983639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical